COMPANY
Topaz Biosciences, Inc.
Funding and NIH signals
- NIH award NIH awarded $576K (SBIR Phase II 5R44AR082722-03, continuation, notice Jul 17, 2026). NIH RePORTER 5R44AR082722-03 (Jul 17, 2026)
Evidence (1 event)
- Jul 17, 2026 · NIH RePORTER 5R44AR082722-03
Organization: TOPAZ BIOSCIENCES, INC.; City/State: EMERYVILLE, CA; Project number: 5R44AR082722-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-17; FY total cost (award amount): 576499; Administering IC: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Project title: Development of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris; Organization type: Domestic For-Profits
- Jul 17, 2026 · NIH RePORTER 5R44AR082722-03